// COMPANY
Craif
SECTOR BIOTECHMENTIONS 2LAST SEEN AUGUST 19, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·PitchBook News·AUGUST 19, 2026
“Craif, a Japanese developer of urine-based cancer tests, raised a $33 million Series D.”
Source→02
funding·StrictlyVC·AUGUST 19, 2026
“Craif | Urine-based cancer detection, Tokyo | $33M Series D; total raised $88M”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.